GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) Peptide
Quick Overview for GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) Peptide (ABIN939641)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- KAPKARVPDL DKRKYLVPSD LTVGQFYFLI RKRIHLRPED ALFFFVNNTI
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GABARAPL1 antibody,
Alternative Names: GABARAPL1 control peptide, GABARAPL1 antibody Blocking Peptide, Anti-GABARAPL1 Blocking Peptide, Gaba A receptor-associated protein like 1 Blocking Peptide, APG8L Blocking Peptide, ATG8 Blocking Peptide, ATG8L Blocking Peptide, GEC1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
-
Background
- GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
-
Molecular Weight
- 14 kDa
Target
-